Bacteriophages as anti-infective agents: recent developments and regulatory challenges.

Abstract

The biennial meeting on 'Exploiting Bacteriophages for Bioscience, Biotechnology and Medicine', held in London, UK, on 20 January 2012, and chaired by George Salmond (University of Cambridge, UK) hosted over 50 participants representing 13 countries. The highly multidisciplinary meeting covered a diverse range of topics, reflecting the current expansion of interest in this field, including the use of bacteriophages as the source of biochemical reagents for molecular biology, bacteriophages for the treatment of human and animal diseases, bacteriophage-based diagnostics and therapeutic delivery technologies and necessity for, and regulatory challenges associated with, robust clinical trials of phage-based therapeutics. This report focuses on a number of presentations from the meeting relating to cutting-edge research on bacteriophages as anti-infective agents.

• Authors: Brendan F Gilmore
• Journal: Expert review of anti-infective therapy (Expert Rev Anti Infect Ther) Vol. 10 Issue 5 Pg. 533-5 (May 2012) ISSN: 1744-8336 [Electronic] England
• PMID: 22702317 (Publication Type: Journal Article)

Chemical References

• Anti-Infective Agents

Topics

• Administration, Cutaneous
• Animals
• Anti-Infective Agents (administration & dosage, chemistry, pharmacology)
• Bacteria (chemistry, virology)
• Bacterial Infections (microbiology, therapy)
• Bacteriophages (chemistry, growth & development, pathogenicity)
• Biofilms
• Biological Therapy (methods)
• Clinical Trials as Topic
• Congresses as Topic
• Drug Evaluation, Preclinical (standards)
• Humans
• Legislation, Drug
• Virus Replication